You are here:
Publication details
Retrospektivní zhodnocení vlivu adjuvantní chemoterapie na čas do progrese a přežití po resekci nemalomuněčného bronchogenního karcinomu v běžné klinické praxi
Title in English | A retrospective evaluation of the effect of adjuvant chemotherapy on time to progression and survival after resection non-small-cell lung carcinoma in routine clinical practice |
---|---|
Authors | |
Year of publication | 2015 |
Type | Conference abstract |
MU Faculty or unit | |
Citation | |
Description | Clinical studies have statistically proven to reduce the risk of relapse and prolonging the time to progression and survival in patients after radical resection of non-small cell lung cancer (NSCLC). Based on these data, it is now recommended adjuvant chemotherapy after radical resection of NSCLC in stages II-IIIA. |